Articles in this section miR Scientific is proud to announce the commercial availability of the miR Sentinel™ Prostate Cancer Test Mir Scientific and Leonie Hill Capital Announce Collaboration to Introduce Breakthrough Urine Liquid Biopsy Prostate Cancer Test in Singapore Journal of Urology Article Mir Scientific Presents Groundbreaking Data on the Exceptional Accuracy of its Prostate Cancer Liquid-Biopsy Test Noninvasive miR Sentinel PCC4 Test accurately identifies prostate cancer Journal of Urology Article May 13, 2022 03:54 Updated Please click here to view our article featured in the Journal of Urology. Related articles Noninvasive miR Sentinel PCC4 Test accurately identifies prostate cancer Mir Scientific and Leonie Hill Capital Announce Collaboration to Introduce Breakthrough Urine Liquid Biopsy Prostate Cancer Test in Singapore Mir Scientific Presents Groundbreaking Data on the Exceptional Accuracy of its Prostate Cancer Liquid-Biopsy Test Is the test available in stores?
